Not so ‘NICE’ clinical guideline!

Like it’s not hard enough already!

Thanx to the new ‘NICE’ clinical guideline treatments have been rejected

The treatments Sativex and Fampyra were rejected on the grounds of being too expensive

Click the link to read more!

MS Society responds to new NICE clinical guideline on MS | Multiple Sclerosis Society UK http://www.mssociety.org.uk/ms-news/2014/10/ms-society-responds-new-nice-clinical-guideline-ms-0 (Share from CM Browser)